from Yahoo Finance https://ift.tt/2YXxVPV
-
LabCorp expands availability of at-home sample collection kit for COVID-19 testing
from Yahoo Finance https://ift.tt/2T1fHcN
-
U.S. FDA declines to review Bristol Myers, bluebird therapy for multiple myeloma
from Yahoo Finance https://ift.tt/2WUgWeC
The Latest
-
What to look for when companies report their post COVID-19 results
-
Why AusCann, Phoslock, Kogan, & Village Roadshow are dropping lower
-
ASX cannabis shares see mixed recovery
-
Why the Race Oncology share price opened 75% higher this morning